Environmental and genetic risk factors associated with venous thromboembolism

M Crous-Bou, LB Harrington… - Seminars in thrombosis …, 2016 - thieme-connect.com
Venous thromboembolism (VTE) includes deep vein thrombosis and pulmonary embolism,
and a combination of environmental and genetic risk factors contributes to VTE risk. Within …

Polygenic risk scores: An overview from bench to bedside for personalised medicine

B Cross, R Turner, M Pirmohamed - Frontiers in Genetics, 2022 - frontiersin.org
Since the first polygenic risk score (PRS) in 2007, research in this area has progressed
significantly. The increasing number of SNPs that have been identified by large scale GWAS …

A clinical-genetic risk score for predicting cancer-associated venous thromboembolism: a development and validation study involving two independent prospective …

A Muñoz, C Ay, E Grilz, S López, C Font… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE Venous thromboembolism (VTE) is a leading cause of death among patients with
cancer. The Khorana score was developed for assessing the risk of VTE in outpatients with …

Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer

AJ Munoz Martin, I Ortega, C Font, V Pachón… - British journal of …, 2018 - nature.com
Background Venous thromboembolism (VTE) is a leading cause of death among patients
with cancer. Outpatients with cancer should be periodically assessed for VTE risk, for which …

CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods

Genome biology, 2024 - Springer
Abstract Background The Critical Assessment of Genome Interpretation (CAGI) aims to
advance the state-of-the-art for computational prediction of genetic variant impact …

CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods

S Jain, C Bakolitsa, SE Brenner, P Radivojac… - Genome …, 2024 - lirias.kuleuven.be
Abstract Background: The Critical Assessment of Genome Interpretation (CAGI) aims to
advance the state-of-the-art for computational prediction of genetic variant impact …

Genetic risk factors in venous thromboembolism

C Hotoleanu - Thrombosis and Embolism: from Research to Clinical …, 2017 - Springer
Genetic risk factors predispose to thrombophilia and play the most important etiopathogenic
role in venous thromboembolism (VTE) in people younger than 50 years old. At least one …

[HTML][HTML] The UCLA ATLAS Community Health Initiative: promoting precision health research in a diverse biobank

R Johnson, Y Ding, A Bhattacharya, S Knyazev, A Chiu… - Cell genomics, 2023 - cell.com
Summary The UCLA ATLAS Community Health Initiative (ATLAS) has an initial target to
recruit 150,000 participants from across the UCLA Health system with the goal of creating a …

Prediction of primary venous thromboembolism based on clinical and genetic factors within the UK Biobank

DA Kolin, S Kulm, O Elemento - Scientific reports, 2021 - nature.com
Both clinical and genetic factors drive the risk of venous thromboembolism. However,
whether clinically recorded risk factors and genetic variants can be combined into a clinically …

[HTML][HTML] Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factors

M Bruzelius, M Bottai, M Sabater‐Lleal… - Journal of Thrombosis …, 2015 - Elsevier
Background Family history of venous thromboembolism (VTE) has been suggested to be
more useful in risk assessment than thrombophilia testing. Objectives We investigated …